Retour
Fourchette du Jour
71,39 €
79,48 €
Fourchette 52 Semaines
26,20 €
84,56 €
Volume
2 140 510
Moyenne 50J / 200J
71,39 €
/
55,53 €
Clôture Précédente
79,24 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -15,8 | 0,3 |
| P/B | 4,5 | 2,9 |
| ROE % | -31,6 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
105,63 €
+44.7%
Low: 83,00 €
High: 137,00 €
BPA Prévisionnel
-4,68 €
CA Est.
0
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-0,96 €
-0,96 € – -0,96 €
|
800 M | 4 |
| FY2029 |
-5,90 €
-5,90 € – -5,90 €
|
200 M | 4 |
| FY2028 |
-6,59 €
-11,69 € – -4,90 €
|
14 M | 10 |
Points Clés
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -232,60M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-31,57%
ROIC-23,47%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,01
Current Ratio26,57
Interest Coverage0,00
Valorisation
P/E Ratio
-15,80
P/B Ratio4,47
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -255,84M |
| ROE | -31,57% | ROA | -27,30% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -232,60M |
| ROIC | -23,47% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 26,57 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -15,80 | P/B Ratio | 4,47 |
| P/S Ratio | N/A | PEG Ratio | -0,64 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 4,04B | Enterprise Value | 3,92B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -255,84M | -182,15M | -83,99M | -39,79M |
| EPS (Diluted) | -4,22 | -3,30 | -1,66 | -0,79 |
| Gross Profit | -1,42M | 0,0 | 0,0 | 0,0 |
| Operating Income | -285,60M | -216,87M | -93,00M | -30,73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 937,13M | 753,95M | 401,40M | 152,06M |
| Total Liabilities | 33,25M | 37,16M | 21,49M | 9,98M |
| Shareholders' Equity | 903,88M | 716,79M | 379,91M | 142,08M |
| Total Debt | 8,85M | 11,83M | 2,03M | 0,0 |
| Cash & Equivalents | 131,55M | 141,79M | 118,32M | 151,89M |
| Current Assets | 741,36M | 529,71M | 398,41M | 152,06M |
| Current Liabilities | 27,91M | 28,56M | 20,56M | 9,98M |